Research Topic · Peer-Reviewed

Adenocarcinoma of the Lung

Adenocarcinoma of the lung is a type of non-small cell lung cancer that arises from glandular epithelial cells, typically those involved in producing mucus or lining the distal airways and alveoli. It is the most common histological form of lung cancer in many populations, including among individuals who have never …

Curated from this journal's research 📚 5 peer-reviewed articles cited Cited 33× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed July 2026

Overview

Adenocarcinoma of the lung is a type of non-small cell lung cancer that arises from glandular epithelial cells, typically those involved in producing mucus or lining the distal airways and alveoli. It is the most common histological form of lung cancer in many populations, including among individuals who have never smoked, and tends to develop in the peripheral regions of the lung. Histologically it is recognized by gland formation, papillary or lepidic growth patterns, and mucin production, with subtypes ranging from indolent in situ lesions to invasive disease. A defining feature of pulmonary adenocarcinoma is its association with actionable molecular alterations, including mutations in the epidermal growth factor receptor, rearrangements of ALK and ROS1, and other driver changes that have become central to treatment selection. Tumors may grow and spread for a prolonged period before producing symptoms such as persistent cough, dyspnea, chest discomfort, or signs of metastasis. Diagnosis combines imaging, biopsy, and increasingly comprehensive molecular profiling alongside testing for immunotherapy biomarkers. Treatment is stage-dependent and may include surgical resection, radiation, cytotoxic chemotherapy, targeted agents directed at specific driver mutations, and immune checkpoint inhibitors. Continued research into tumor genomics, resistance pathways, and early detection aims to improve outcomes in this clinically and molecularly heterogeneous disease.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 5 articles above have been cited 33 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Adenocarcinoma of the Lung, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.